Overlapping pathways to transplant glomerulopathy: Chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy

Kidney International

Volumn 80, Issue 8, 2011, Pages 879-885

  Baid Agrawal, Seema ^a   Farris, Alton B ^b   Pascual, Manuel ^c   Mauiyyedi, Shamila ^d   Farrell, Mary Lin ^e   Tolkoff Rubin, Nina ^e   Collins, A Bernard ^e   Frei, Ulrich ^a   Colvin, Robert B ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF TEXAS   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

antibody mediated rejection; hepatitis; kidney transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LEUKOCYTE ANTIGEN; PREDNISONE;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 80053505006     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.194     Document Type: Article

References (52)

1. Porter KA, Dossetor JB, Marchioro TL et al. Human renal transplants. I. Glomerular changes. Lab Invest 1967; 16: 153-181.
2. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056. (Pubitemid 46536891)
3. Cosio FG, Gloor JM, Sethi S et al. Transplant glomerulopathy. Am J Transplant 2008; 8: 492-496. (Pubitemid 351287536)
4. Maryniak RK, First MR, Weiss MA. Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int 1985; 27: 799-806. (Pubitemid 15064642)
5. Habib R, Broyer M. Clinical significance of allograft glomerulopathy. Kidney Int Suppl 1993; 43: S95-S98.
6. Shu KH, Lu YS, Chang CH et al. Transplant glomerulopathy-a clinicopathological study. Transplant Proc 1996; 28: 1527-1528.
7. Suri DL, Tomlanovich SJ, Olson JL et al. Transplant glomerulopathy as a cause of late graft loss. Am J Kidney Dis 2000; 35: 674-680. (Pubitemid 30185513)
8. Banfi G, Villa M, Cresseri D et al. The clinical impact of chronic transplant glomerulopathy in cyclosporine era. Transplantation 2005; 80: 1392-1397. (Pubitemid 41803618)
9. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743-1752. (Pubitemid 46905427)
10. Cosio FG, Grande JP, Wadei H et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464-2472.
11. Gloor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124-2132. (Pubitemid 47247042)
12. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574-582. (Pubitemid 32180027)
13. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380. (Pubitemid 34925248)
14. Vongwiwatana A, Gourishankar S, Campbell PM et al. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004; 4: 124-129.
15. Kieran N, Wang X, Perkins J et al. Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol 2009; 20: 2260-2268.
16. Hidalgo LG, Campbell PM, Sis B et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532-2541.
17. Nickeleit V, Zeiler M, Gudat F et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242-251. (Pubitemid 34042034)
18. Akalin E, Dinavahi R, Dikman S et al. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007; 2: 1261-1267.
19. John R, Konvalinka A, Tobar A et al. Determinants of long-term graft outcome in transplant glomerulopathy. Transplantation 2010; 90: 757-764.
20. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723. (Pubitemid 29082898)
21. Papadimitriou JC, Drachenberg CB, Munivenkatappa R et al. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation 2010; 90: 1478-1485.
22. Ponticelli C, Banfi G. Transplant glomerulopathy: new clues in the puzzle of chronic allograft nephropathy? Am J Transplant 2003; 3: 1043-1044.
23. Andresdottir MB, Assmann KJ, Koene RA et al. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Am J Kidney Dis 1998; 32: 582-588. (Pubitemid 28477703)
24. Pascual M, Perrin L, Giostra E et al. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-570. (Pubitemid 20239986)
25. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
26. Johnson RJ, Willson R, Yamabe H et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994; 46: 1255-1263. (Pubitemid 24330702)
27. Pascual M, Schiferli J. Hepatitis C virus infection and glomerulonephritis. In: Andreucci V, Fine L (eds). International Yearbook of Nephrology. Oxford University Press: New York, 1996, pp 20-26.
28. Sansonno D, Gesualdo L, Manno C et al. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25: 1237-1244. (Pubitemid 27199954)
29. DAmico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54: 650-671. (Pubitemid 28357431)
30. Roth D, Cirocco R, Zucker K et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995; 59: 1676-1682.
31. Cruzado JM, Gil-Vernet S, Ercilla G et al. Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. J Am Soc Nephrol 1996; 7: 2469-2475. (Pubitemid 27465955)
32. Baid S, Cosimi AB, Tolkoff-Rubin N et al. Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation 2000; 70: 255-261. (Pubitemid 30602737)
33. Gallay BJ, Alpers CE, Davis CL et al. Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995; 26: 662-667.
34. Cosio FG, Roche Z, Agarwal A et al. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996; 28: 752-758. (Pubitemid 26363905)
35. Cruzado JM, Carrera M, Torras J et al. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001; 1: 171-178. (Pubitemid 33674158)
36. Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481-508.
37. Satoskar AA, Pelletier R, Adams P et al. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant 2010; 10: 1804-1811.
38. Baid S, Pascual M, Williams Jr WW et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999; 10: 146-153. (Pubitemid 29034953)
39. Baid S, Pascual M, Cosimi AB et al. Viruses and thrombotic microangiopathy. Transplantation 1999; 68: 710-711.
40. Wong W, Denton M, Rennke HG et al. Hepatitis C, proteinuria, and renal insufficiency. Am J Kidney Dis 2004; 44: 924-929. (Pubitemid 39445928)
41. Namba Y, Oka K, Moriyama T et al. Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation. Clin Transplant 2006; 20(Suppl 15): 20-25. (Pubitemid 44122719)
42. Sis B, Jhangri GS, Bunnag S et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
43. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15: 42-48.
44. Rubin RH. Impact of Cytomegalovirus Infection on Renal Transplantation, 3rd edn. Marcel Dekker: New York, 1998.
45. Cacoub P, Ghillani P, Revelen R et al. Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia. J Hepatol 1999; 31: 598-603. (Pubitemid 29487679)
46. Baid-Agrawal S, Pascual M, Moradpour D et al. Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol 2008; 18: 97-115. (Pubitemid 351428341)
47. Sijpkens YW, Joosten SA, Wong MC et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 2409-2418. (Pubitemid 38670027)
48. Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979; 27: 1131-1139. (Pubitemid 9246245)
49. Hsu SM, Raine L. The use of avid-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: DeLellis RA (ed) Advances in Immunohistochemistry. Masson: New York, 1984, pp 31-42.
50. Schneeberger EE, Collins AB, Latta H et al. Diminished glomerular accumulation of colloidal carbon in autologous immune complex nephritis. Lab Invest 1977; 37: 9-19. (Pubitemid 8145770)
51. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214. (Pubitemid 29453499)
52. Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol 1972; 34: 187-220.